Belcher Pharmaceuticalsmanufacturing

Belcher’s knowledgeable staff and state-of-the-art facility can support development and manufacture of all solid dosage forms (including DEA compliant controlled products) with either immediate or modified release profiles. Our extensive pharmaceutical development and testing capabilities can support products throughout the development from lab-scale to pilot scale-up to commercial launch phases, while adhering to the highest cGMP standards. The facility meets Class 100,000 specifications. You are assured that all our contract manufacturing projects will have:

  • Expertise in technology transfer processes
  • Timely delivery
  • Custom tailored orders
  • Full regulatory support
  • Dedicated project coordinator and customer service representatives
  • Cost effective solutions

If you are considering us for a technology transfer we can assist you on all aspects of the manufacturing and analytical testing process. We offer the following solid dosage form capabilities:
Belcher uses high-speed, state-of-the-art processing equipment for on-time delivery and consistent batch results.

Belcher Pharmceuticals operates according to meticulous Standard Operating Procedures (SOPs) in strict compliance with current Good Manufacturing Practices (cGMPs) in our 65,000 square-foot manufacturing facilities.

  • Thorough vendor evaluation and raw material certification processes.
  • Technologically advanced equipment monitored by industry veterans.
  • Experienced quality assurance professionals oversee all phases of manufacturing.



Belcher manufacturing capabilities include the following:

  • Tablets (uncoated, film-coated, enteric-coated and sugar-coated)
  • Capsules
  • Modified release tablets and capsules (extended release, delayed release and long acting)
  • Pellets (immediate and time release seeds)
  • Powders
  • Granules
  • Emulsion / Topicals
  • Liquids
  • Controlled Substances
  • Beta Lactam antibiotics
  • Cephlasporin antibiotics